Drawing for THE POWER OF REVERSIBLE PROTEASOME INHIBITION

USPTO serial 77478756

THE POWER OF REVERSIBLE PROTEASOME INHIBITION

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
ALTREE, NICHOLAS
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with THE POWER OF REVERSIBLE PROTEASOME INHIBITION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Nancy C. DiConza

NANCY C. DICONZA FROSS ZELNICK LEHRMAN & ZISSU, P.C.866 UNITED NATIONS PLZNEW YORK, NY 10017-1822UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005prescription pharmaceutical preparations for use in the diagnosis or treatment of human diseases and disorders, namely, oncologic diseases and disorders, excluding analgesicsACTIVE—
040research services, namely, research, development, validation, testing, data analysis and product development services in the biomedical, genomic, pharmacogenomic, diagnostic, clinical trial design, and biotechnology fields; research consulting services, namely, research, development, validation, testing, data analysis, and product development services for others in the biomedical, genomic, pharmaceutical, pharmacogenomics, diagnostic, clinical trial design, and biotechnology fields; consultation services, namely, providing consultation to others via global, national, and local computer networks in the fields of life sciences, pharmacogenomics, diagnostics, clinical trial design and biotechnology; providing on-line computer databases via global, national, and local computer networks in the fields of life sciences, pharmacogenomics, diagnostics, clinical trial design and biotechnologyACTIVE—
044medical services and medical diagnostic services, namely, diagnosing, preventing, and predicting disease, identifying hereditary risk factors, diagnostic testing, prognostic testing, gene and protein testing, identifying physiological characteristics, establishing individual preventative programs, establishing disease treatment based on gene and protein expression and/or activity, evaluating clinical trial progress, drug monitoring and computer tracking of a patient's health progressACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jan 23, 2012MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 23, 2012ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 16, 2011EXRANOTICE OF APPROVAL OF EXTENSION REQUEST MAILED—
Jun 15, 2011EX5GSOU EXTENSION 5 GRANTED—
Jun 10, 2011EXT5SOU EXTENSION 5 FILED—
Jun 10, 2011EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 27, 2010EXRANOTICE OF APPROVAL OF EXTENSION REQUEST MAILED—
Nov 26, 2010EX4GSOU EXTENSION 4 GRANTED—
Nov 23, 2010EXT4SOU EXTENSION 4 FILED—
Nov 23, 2010EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 10, 2010EXRANOTICE OF APPROVAL OF EXTENSION REQUEST MAILED—
Jun 9, 2010EX3GSOU EXTENSION 3 GRANTED—
Jun 2, 2010EXT3SOU EXTENSION 3 FILED—
Jun 2, 2010EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 21, 2010EX2GSOU EXTENSION 2 GRANTED—
Jan 21, 2010AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Dec 4, 2009EXT2SOU EXTENSION 2 FILED—
Dec 4, 2009EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 4, 2009EX1GSOU EXTENSION 1 GRANTED—
Jun 4, 2009EXT1SOU EXTENSION 1 FILED—
Jun 4, 2009EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 23, 2008NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 30, 2008PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 10, 2008NPUBNOTICE OF PUBLICATION—
Aug 26, 2008PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Aug 26, 2008ALIEASSIGNED TO LIE—
Aug 16, 2008CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 15, 2008DOCKASSIGNED TO EXAMINER—
May 23, 2008NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance